Trump administration is advancing a plan for peptide drugs favored by RFK Jr., CNBC reports. Peptides have been a regulatory gray zone, so an official push here matters more for the compounding and te

What happened: The Trump administration advanced a plan for peptide drugs favored by RFK Jr. The proposal was quickly praised online by some Kennedy allies who sell peptides. Why it matters: The plan drew praise from Kennedy allies with commercial ties to peptides, signaling possible policy momentum for the category. Total: 296 characters.

High-priority alert based on source significance and keyword relevance.

High-priority alert based on source significance and keyword relevance. — impact context not separately stored; see What changed.